Amorphous carbamazepine stabilization by the mesoporous silicate SBA-15

被引:34
作者
Ambrogi, Valeria [1 ]
Marmottini, Fabio [2 ]
Pagano, Cinzia [1 ]
机构
[1] Univ Perugia, Dipartimento Chim & Tecnol Farmaco, I-06123 Perugia, Italy
[2] Univ Perugia, Dipartimento Ingn Civile & Ambientale, I-06123 Perugia, Italy
关键词
Carbamazepine; Amorphous; SBA-15; Dissolution; Physical stability; DRUG-DELIVERY; SOLID-STATE; POLYMORPHS; BIOAVAILABILITY; ENHANCEMENT; DISSOLUTION; CONVERSION; DIHYDRATE; DIOXIDE; MCM-41;
D O I
10.1016/j.micromeso.2013.04.008
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
The poor solubility carbamazepine (CARBA) is the main responsible for its low and variable bioavailability. This problem is strictly connected to the high energy required for CARBA crystal lattice disruption that represents the rate determining step of the dissolution process. CARBA dissolution enhancement can be achieved by converting the crystals ordered structure in the amorphous solid state in which the molecules show a high mobility, requiring less energy for intermolecular bond breaking. Unfortunately CARBA amorphous form is unstable and turns into the crystalline one. The aim of this work was the improvement of CARBA dissolution by its conversion in the amorphous form and its stabilization by inclusion in the mesoporous silica material SBA-15. CARBA was loaded by a simple, safe and eco-friendly method obtaining a high final drug loading (40% wt.). The obtained inclusion product showed improved drug dissolution and good physical stability in comparison to crystalline CARBA. Interesting results were obtained also for the physical mixture of SBA-15 and CARBA which showed an increase of drug dissolution. Moisture effects on drug amorphous form stability are discussed as well. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 30 条
[1]   Role of mesoporous silicates on carbamazepine dissolution rate enhancement [J].
Ambrogi, Valeria ;
Perioli, Luana ;
Marmottini, Fabio ;
Accorsi, Oriana ;
Pagano, Cinzia ;
Ricci, Maurizio ;
Rossi, Carlo .
MICROPOROUS AND MESOPOROUS MATERIALS, 2008, 113 (1-3) :445-452
[2]   Use of SBA-15 for furosemide oral delivery enhancement [J].
Ambrogi, Valeria ;
Perioli, Luana ;
Pagano, Cinzia ;
Marmottini, Fabio ;
Ricci, Maurizio ;
Sagnella, Anna ;
Rossi, Carlo .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 46 (1-2) :43-48
[3]  
[Anonymous], 1992, APPL PHARMACOKINETIC
[4]   THE DETERMINATION OF PORE VOLUME AND AREA DISTRIBUTIONS IN POROUS SUBSTANCES .1. COMPUTATIONS FROM NITROGEN ISOTHERMS [J].
BARRETT, EP ;
JOYNER, LG ;
HALENDA, PP .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1951, 73 (01) :373-380
[5]   Solubility and conversion of carbamazepine polymorphs in supercritical carbon dioxide [J].
Bettini, R ;
Bonassi, L ;
Castoro, V ;
Rossi, A ;
Zema, L ;
Gazzaniga, A ;
Giordano, F .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 13 (03) :281-286
[6]   Adsorption of gases in multimolecular layers [J].
Brunauer, S ;
Emmett, PH ;
Teller, E .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1938, 60 :309-319
[7]   Hydrothermal stability of SBA-15 and related ordered mesoporous silicas with plugged pores [J].
Celer, Ewa B. ;
Kruk, Michal ;
Zuzek, Yvette ;
Jaroniec, Mietek .
JOURNAL OF MATERIALS CHEMISTRY, 2006, 16 (27) :2824-2833
[8]   Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption [J].
Custodio, Joseph M. ;
Wu, Chi-Yuan ;
Benet, Leslie Z. .
ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (06) :717-733
[9]  
EMEA, 2003, CPMPQWP12202 EMEA
[10]  
FDA CDER, 1997, GUID IND DISS TEST I